Kidney cancer in the Swedish family cancer database: Familial risks and second primary malignancics

被引:53
作者
Czene, KA [1 ]
Hemminki, K [1 ]
机构
[1] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
关键词
heredity; kidney cancer; hemangioblastoma; VHL; second cancer; tumor;
D O I
10.1046/j.1523-1755.2002.00304.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Familial risks in kidney cancer and association with second primary malignancies were studied using the nationwide Swedish Family Cancer Database. Methods: Cancer data were retrieved from the Swedish Cancer Registry from years 1961 to 1998 and included 23,137 cases of kidney cancer. Standardized incidence ratios (SIRs) were used to measure the cancer risks. Results: Seventy-one families were identified where both a parent and an offspring had kidney cancer, giving a familial risk for offspring of 1.56 (1.22 to 1.95) and population attributable proportion of 0.78%. A risk for kidney cancer from an affected sibling was considerably higher with a SIR of 4.72 (2.28 to 9.20), giving an attributable proportion of 0.77%. The discordant tumor site that was associated with kidney cancer between two generations was hemangioblastoma of central nervous system. Discordant cancer sites that were associated with kidney cancer in siblings were ovaries, endocrine glands and pancreas. There was an over threefold increase of second primary malignancies of the urinary bladder, nervous system and endocrine gland in kidney cancer patients. The risks for second primary hemangioblastoma following kidney cancer or familial kidney cancer was 21.19 (6.69 to 43.83) and 1206 (114 to 3456), respectively. Conclusions: The high ratio of sibling risk to offspring risk in kidney cancer may reflect a recessive susceptibility. The high risk for second primary cancers in the patients without family history is consistent with a polygenic model and variable degree of environmental modification.
引用
收藏
页码:1806 / 1813
页数:8
相关论文
共 44 条
[1]  
Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO
[2]  
2-C
[3]   Coincident renal cell carcinoma and nonHodgkin's lymphoma: The M. D. Anderson experience and review of the literature [J].
Anderson, CM ;
Pusztai, L ;
Palmer, JL ;
Cabanillas, F ;
Ellerhorst, JA .
JOURNAL OF UROLOGY, 1998, 159 (03) :714-717
[4]  
[Anonymous], 1994, STAT METHODS CANC RE
[5]   METHODOLOGY FOR EVALUATING THE INCIDENCE OF 2ND PRIMARY CANCERS WITH APPLICATION TO SMOKING-RELATED CANCERS FROM THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM [J].
BEGG, CB ;
ZHANG, ZF ;
SUN, M ;
HERR, HW ;
SCHANTZ, SP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 142 (06) :653-665
[6]   INCREASED RISK OF 2ND PRIMARY MALIGNANCIES IN PATIENTS WITH GYNECOLOGICAL CANCER - A SWEDISH RECORD-LINKAGE STUDY [J].
BERGFELDT, K ;
EINHORN, S ;
ROSENDAHL, I ;
HALL, P .
ACTA ONCOLOGICA, 1995, 34 (06) :771-777
[7]  
Connor M, 1997, ESSENTIAL MED GENETI
[8]  
Dong CH, 2001, INT J CANCER, V92, P144
[9]  
Friedrich CA, 1999, CANCER-AM CANCER SOC, V86, P2478, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO
[10]  
2-5